Eris Lifesciences Limited — Important, 18-07-2025: Updates

Eris Lifesciences (ERIS) has updated its 19th Annual General Meeting (AGM) agenda. The company will defer Agenda Item No. 7, as the reappointment approval sought is deemed premature. All other resolutions (Items 1-6 and 8) will proceed as scheduled, with voting for Item No. 7 to be disabled. This is a minor corporate governance adjustment, with no immediate operational or financial impact on the business.